US2018028504A1PendingUtilityA1
Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder
Est. expiryJan 31, 2031(~4.5 yrs left)· nominal 20-yr term from priority
A61P 25/24A61K 31/554A61K 31/551A61K 31/519A61K 31/42A61K 31/496A61K 31/137A61K 31/5513A61K 45/06
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention provides an oral dosage regimen for the treatment of depression, a pharmaceutically acceptable medication dispensing package containing multiple dosage units of medicaments comprising an oral dosage regimen of D-cycloserine for the treatment of depression, a pharmaceutical composition comprising D-cycloserine formulated for oral administration providing a dosage of 1000 mg/day alone or in combination with antidepressant agents and uses thereof.
Claims
exact text as granted — not AI-modified1 - 66 . (canceled)
67 . A method for treating depression, comprising:
administering an anti-depression effective amount of a NMDAR agonist to a patient in need thereof.
68 . The method of claim 67 , wherein said NMDAR agonist is a partial NMDAR agonist.
69 . The method of claim 68 , wherein said partial NMDAR agonist is D-cycloserine.Join the waitlist — get patent alerts
Track US2018028504A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.